Somalogic Inc (SLGC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2021 | 12-2020 | 09-2020 | |
| Cash Flows From Operating Activities | |||
| Net Income | -9,484 | -53,015 | -44,101 |
| Depreciation Amortization | 988 | 4,438 | 3,590 |
| Accounts receivable | 2,559 | N/A | -3,526 |
| Accounts payable and accrued liabilities | 1,020 | N/A | 2,437 |
| Other Working Capital | 1,149 | -8,667 | -2,015 |
| Other Operating Activity | -123 | 28,906 | 15,864 |
| Operating Cash Flow | $-3,891 | $-28,338 | $-27,751 |
| Cash Flows From Investing Activities | |||
| PPE Investments | -192 | -1,106 | -689 |
| Purchase Of Investment | -77,990 | N/A | -5,738 |
| Sale Of Investment | 2,500 | N/A | 37,273 |
| Other Investing Activity | 0 | -8,429 | 0 |
| Investing Cash Flow | $-75,682 | $-9,535 | $30,846 |
| Cash Flows From Financing Activities | |||
| Change In Short Term Borrowing | N/A | N/A | 3,520 |
| Debt Issued | -206 | N/A | N/A |
| Common Stock Issued | 823 | N/A | 815 |
| Other Financing Activity | 0 | 188,766 | 5,000 |
| Financing Cash Flow | $617 | $188,766 | $9,335 |
| Exchange Rate Effect | -5 | -9 | -15 |
| Beginning Cash Position | 165,194 | 14,310 | 14,310 |
| End Cash Position | 86,233 | 165,194 | 26,725 |
| Net Cash Flow | $-78,961 | $150,884 | $12,415 |
| Free Cash Flow | |||
| Operating Cash Flow | -3,891 | -28,338 | -27,751 |
| Capital Expenditure | -192 | N/A | -689 |
| Free Cash Flow | -4,083 | -28,338 | -28,440 |